From Twitter - No tweets available at the moment.

Browsing: Slimming pills

What is slim 365 ?

August 18th, 2009 | By

Slim 365 is a new slimming pill in the market, they are made from three potential ingredients which are: Hoodia, Green tea and Chitosan. And these mixed ingredient were supposedly can help you lose weight, the bottle state that it can block, burn and ban fat.

For the ingredient it self I am certain that these three ingredients are certainly great for weight loss or slimming process but remember that there are no magical pills and what specific effect that you want to help you in weight loss or slimming process.

Hoodia Gordonii – a common cactus in Africa that has the P57 substance in it which could help you suppress your appetite. Read the long version about Hoodia.

Green tea – an antioxidant tea that believed to be can help you increase metabolism which lead to a more active you.

Chitosan – a natural fiber taken from the exoskeleton of a crustaceous that has the ability to reduce cholesterol level and due to its natural fiber suppress your appetite.

Looking at the three ingredient certainly this product great right? Well our team isn’t sure about that cause the claim and the product ingredient potential effect just doesn’t suit with the product claim that it could burn, block and ban the fat right? So… where the fat burning effect ingredient and where the fat blocker ingredient and where the component that could ban the fat? Okay maybe green tea has a 17% of fat oxidation then what the Hoodia and Chitosan role is?

Nevertheless these ingredients are certainly are good for you but to be honest we doubt that this slimming pill would be effective in your slimming process. If you have tried this product please let us know by contacting us.

    Resources -Slim 365 is a new slimming pill in the market, they are made from three potential ingredients which are: Best weight loss pills, Green tea and Chitosan. 5 diet myths

    Sea of Love dvd

    A new slimming Pills Qnexa has invented

    April 19th, 2009 | By

    There is hope that a new diet pill may soon hit the market after drug development firm Vivus announced very promising results from their late-stage trial into their slimming pill Qnexa.

    Saving Private Ryan ipod

    They said that following two randomised Stage III trials they were confident that their medication met the benchmarks demanded by the FDA for approval and that they would be seeking permission to sell the drug next year. They plan now to find a pharmaceutical company to help market the product.

    The first trial involved some 1,267 morbidly obese patients and the second 2,487 who were overweight or obese and also had other health problems, such as diabetes or high blood pressure.

    Vivus said that after a year of taking the medication, the patients in the one group taking the highest dose of Qnexa lost on average 10.4% of their total body weight, while those in the other trial lost an average 11%, compared to the placebo group who lost between 1.6 to 1.8%.

    Overall this means that the diet pills caused an average weight loss of 9% on average, after the placebo effect was taken into account. This more than meets the FDA’s requirements for any new slimming pill, which demands that patients lose at least 5% of their body weight.

    The data also showed that on one trial, 67% of patients taking the drug lost at least 5% of their body weight, compared to 17% taking the placebo. On the other trial  the percentage was even higher, with 70% of patients taking the weightloss pills losing the required amount compared to 20% of those in the placebo group.

    The race is now on between three companies to see who first gets their weight loss pills on the market. Orixigen Therapeutics are developing Contrave and also recently published promising late trial results. Arena Pharmaceuticals are also hoping to get their slimming pills, lorcaserin, onto the market soon.

    The potential for gain for whichever company manages it first is huge. At the moment there are only two diet pills that are licensed for prescription by the FDA and European regulators, Reductil and Xenical. Reductil is an appetite suppressant while Xenical limits the amount of dietary fat absorbed by the body.

    If Vivus or one of their competitors manages to get another weight loss solution approved then they stand to grab a large chunk of sales, which in total are worth an estimated $10 billion a year. A market analyst told Bloomberg earlier in October that Qnexa could generate sales of up to $3 billion a year if the slimming pill received approval.


    Romeo + Juliet video